title: Role of p53 isoforms and aggregations in cancer.
abstract: p53 is a master regulatory protein that is involved in diverse cellular metabolic processes such as apoptosis, DNA repair, and cell cycle arrest. The protective function of p53 (in its homotetrameric form) as a tumor suppressor is lost in more than 50% of human cancers.Despite considerable experimental evidence suggesting the presence of multiple p53 states, it has been difficult to correlate the status of p53 with cancer response to treatments and clinical outcomes, which suggest the importance of complex but essential p53 regulatory pathways.Recent studies have indicated that the expression pattern of p53 isoforms may play a crucial role in regulating normal and cancer cell fates in response to diverse stresses. The human TP53 gene encodes at least 12 p53 isoforms, which are produced in normal tissue through alternative initiation of translation, usage of alternative promoters, and alternative splicing. Furthermore, some researchers have suggested that the formation of mutant p53 aggregates may be associated with cancer pathogenesis due to loss-of function (LoF), dominant-negative (DN), and gain-of function (GoF) effects.As different isoforms or the aggregation state of p53 may influence tumorigenesis, this review aims to examine the correlation of p53 isoforms and aggregation with cancer.
authors.affiliation: Department of Bionano Technology, Gachon University, Gyeonggi-do, Republic of Korea.
authors.forename: SeJin
authors.initials: S
authors.lastname: Kim
authors.forename: Seong Soo A
authors.initials: SS
authors.lastname: An
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000209:etiology*; D020033:Protein Isoforms / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*
chemical_list: D020033:Protein Isoforms; D016159:Tumor Suppressor Protein p53